1. Rigel DS, Friedman RJ, Kopf AW. Lifetime risk for development of skin cancer in the U.S. population: current estimate is now 1 in 5. J Am Acad Dermatol. 1996;35(6):1012–3. https://doi.org/10.1016/S0190-9622(96)90139-5.
2. Types of skin cancer. https://www.aad.org/public/diseases/skin-cancer/types/common. Accessed Jul 12, 2021.
3. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. https://doi.org/10.3322/caac.21654.
4. Jørgensen JT. The current landscape of the FDA approved companion diagnostics. Transl Oncol. 2021;14(6):101063. https://doi.org/10.1016/j.tranon.2021.101063.
5. Salah S, Khurana P, Balan D, Pardieu-Duthil L, Kerob D, Passeron T. “A comprehensive analysis of global skin cancer incidence and mortality with a focus on dermatologist density and population risk factors,” presented at the EADV Congress, EADV Congress 11–14 October, Berlin, Oct. 2023. https://s3.eu-central-1.amazonaws.com/m-anage.com.storage.eadv/abstracts_congress2023/37072.pdf. Accessed 17 July 2024.